2m 2m 2m 2m 2m 2m 2m
Anika Therapeuti (ANIK)
NASDAQ
$21.03-$0.07 (-0.31%)
Price as of Oct 22, 2026 7:30 PM EDT- $275.7MMarket Cap
- 115.03%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Anika Therapeuti (ANIK)
$21.03-$0.07 (-0.31%)
ANIK | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $21.09 | ||
Change | +$0.16 (+0.78%) | ||
Open | $20.38 | ||
High | $21.09 | ||
Low | $20.11 | ||
Previous Close | $20.60 | ||
Volume | 61,425 | ||
30-Day Average Volume | 108,003 | ||
1-Week Change | 1.73% | ||
1-Month Change | -0.48% | ||
1-Year Change | 115.03% | ||
3-Year Change | 9.17% | ||
5-Year Change | -50.46% | ||
Fundamentals | |||
Shares Outstanding | 13.4M | ||
Total Assets | $183.5M | ||
Market Cap | $275.7M | ||
Enterprise Value | $237.3M | ||
Period: QTR TTM FY | |||
Revenue | $32.6M | ||
Net Income | $3.3M | ||
Free Cash Flow | -$2.1M | ||
EBIT | $3.4M | ||
EBITDA | $4.9M | ||
Net Working Capital | $77.0M | ||
EPS | $0.24 | ||
Enterprise Value/EBITDA | 49 | ||
Enterprise Value/Revenue | 7 | ||
P/B | 2 | ||
P/E | 86 | ||
PEG | 1 | ||
Price/Free Cash Flow | -129 | ||
Price/Operating Cash Flow | -403 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue